In vitro cytotoxicity of cis[((1R,2R)-1,2-cyclohexanediamine- N,N')bis(myristato)] platinum(II) suspended in lipiodol in rat hepatoma AH- 109A cells and human tumor cell lines

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 4, 2000, Pages 487-491

  Kishimoto, Shuichi ^a   Noguchi, Toshihiro ^b   Yamaoka, Takashi ^b   Fukushima, Shoji ^a   Takeuchi, Yoshikazu ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Cisplatin (CDDP); Cytotoxicity; Hepatocellular carcinoma; Lipiodol; Lipophilic platinum; Sustained release

Indexed keywords

CISPLATIN; IODINATED POPPYSEED OIL; PLATINUM 1,2 DIAMINOCYCLOHEXANE; SM 11355;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLONY FORMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; RAT; SUSTAINED DRUG RELEASE;

EID: 0034099068     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.487     Document Type: Article

References (18)

1. Minoyama A., Yoshikawa M., Ebara M., Saisho H., Sugiura N., Ohto M., J. Gastroenterol., 30, 355-366 (1995).
2. Rougier P., Munck J. N., Elias D., Herait P., Bongel C., Gosse C., Lasset P., Am. J. Clin. Oncol., 13, S1-S4 (1990).
3. Vexler A. M., Mou X., Gabizon A. A., Gorodetsky R., Int. J. Cancer, 60, 611-615 (1995).
4. Yamada R., Kishi K., Sato M., Sonomura T., Nishida N., Tanaka K., Shinoyama Y., Terada M., Kimura M., World J. Surg., 19, 795-800 (1995).
5. Aigner K. R., Semin. Surg. Oncol., 14, 248-253 (1998).
6. Iwai K., Maeda H., Konno T., Cancer Res., 44, 2115-2121 (1984).
7. Konno T., Cancer, 66, 1897-1903 (1990).
8. Yamashita Y., Takahashi M., Bussaka H., Fukushima S., Kawaguchi T., Nakano M., Cancer, 64, 2437-2444 (1989).
9. Shibata J., Fujiyama S., Sato T., Kishimoto S., Fukushima S., Nakano M., Cancer, 64, 1586-1594 (1989).
10. Bayraktar Y., Balkanci F., Kayhan B., Uzunalimoglu B., Gokoz A., Ozihik Y., Gurakar A., Van Theil D. H., Filat D., Hepatogastroenterology, 43, 681-687 (1996).
11. Hirashima N., Sakakibara K., Itazu I., Hirai T., Nemoto A., Matsuura H., Kumada K., Nojiri O., Kano H., Semin. Oncol., 24, S6-91-S6-96 (1997).
12. Kishimoto S., Fukui M., Fukushima S., Nakano M., Reg. Cancer Treat., 1-2, 25-29 (1992).
13. Ono Y., Yoshioka H., Ohkusa A., Okafuji T., Kawakami A., Ishida O., Suzuki T., Fukui M., J. Jpn. Soc. Cancer Ther., 27, 49-58 (1992).
14. Fukushima S., Kawaguchi T., Nishida M., Juni K., Yamashita Y., Takahashi M., Makano M., Cancer Res., 47, 1930-1934 (1987).
15. Fukushima S., Kishimoto S., Hayashi Y., Kaneko M., Nakano M., Shibata J., Fujiyama S., Sato T., J. Jpn. Soc. Cancer Ther., 23, 2743-2749 (1988).
16. Furuta T., Kanmatsu T., Kakizoe S., Sugimachi K., J. Surg. Oncol., 39, 229-234 (1988).
17. Perez-Solar R., Yang L. I., Drewinko B., Lauterzstain J., Khokhar A. R., Cancer Res., 48, 4509-4512 (1988).
18. Han I., Khokhar A. R., Perez-Soler R., Cancer Chemother. Pharmacol., 39, 17-24 (1996).